Tytuł artykułu

Survivin expression in correlation with apoptotic activity in canine lymphomas

Tytuł czasopisma

Polish Journal of Veterinary Sciences




No 2


Wydział PAN

Nauki Biologiczne i Rolnicze


University of Warmia and Mazury in Olsztyn ; Polish Academy of Sciences Committee of Veterinary Sciences




ISSN 1505-1773


Sarela (2002), Expression of survivin a novel inhibitor of apoptosis and cell cycle regulatory protein in pancreatic adenocarcinoma, AI Cancer, 886. ; Lossos (2003), IS Higher grade transformation of follicular lymphoma : phenotypic tumor progression associated with diverse genetic lesions, Semin Cancer Biol, 13, 191. ; Zhou (2002), DNA damage induces a novel survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells, J Pharmacol Exp Ther, 53. ; Tracey (2005), Expression of the kappaB targets Survivin characterizes small cell and aggressive cell lymphomas respectively, J Pathol, 206. ; Graaf (2005), de van de de der Expression of Survivin discriminates different types of lymphoid malignancies, null, 130. ; Ambrosini (1997), novel anti gene survivin expressed in cancer and lymphoma, apoptosis Nat Med, 917. ; Garg (2016), a unique target for tumor therapy, Cancer Cell Int, 16. ; Grossman (2001), Inhibition of melanoma tumor growth in vivo by survivin targeting, Proc Natl Acad Sci USA, 635. ; Shamsabadi (2016), a Promising Gene for Targeted Treatment Asian, Cancer Cancer, 17, 3711. ; Tamura (2000), Specificity of TUNEL method depends on duration of fixation, Biotech Histochem, 197. ; Markovic (2011), Clinical and prognostic significance of apoptotic profile in patients with newly diagnosed nodal diffuse large lymphoma, cell Eur J Haematol, 246. ; Shin (2001), BH An anti - apoptotic protein human survivin is a direct inhibitor of caspase -, Biochemistry, 1117. ; Li (2006), Expression of survivin in human non - Hodgkin lymphoma and its correlation with proliferation and angiogenesis, J Huazhong Univ Sci Technolog Med Sci, 26, 504. ; Symmans (2000), Apoptotic index from fine needle aspiration cytology as a criterion to predict histologic grade of non - Hodgkin s lymphoma, Acta Cytol, 194. ; Li (2005), Nuclear or cytoplasmic expression of survivin : what is the significance, Int J Cancer, 114. ; Mellai (2008), Survivin expression in glioblastomas correlates with proliferation but not with apoptosis, Anticancer Res, 28, 109. ; Sokołowska (null), Survivin expression in canine lymphomas in relation with proliferative markers, Pol J Vet Sci, 18, 2015. ; Fu (2014), Prognostic utility of apoptosis index and survivin expression in dogs with nasal carcinoma treated with orthovoltage radiation therapy, J Vet Med Sci, 67. ; Ito (2000), promotes cell proliferation in human hepatocellular carcinoma, Hepatology, 31, 1080. ; Zhou (2007), XL Expression of survivin and protein in cell non lymphoma and their effects on cell apoptosis and proliferation, null, 15, 99. ; Ponce (2010), morphological study of cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology, Vet Pathol, 608. ; Ansell (2004), Inhibition of survivin expression suppresses the growth of aggressive non lymphoma, Leukemia, 18, 616. ; Kuttler (2002), Relationship between expression of genes involved in cell cycle control and apoptosis in diffuse large cell lymphoma : a preferential survivin - cyclin link, Leukemia, 16, 726. ; Rebhun (2008), Comparative analysis of survivin expression in untreated and relapsed canine lymphoma, J Vet Intern Med, 22, 989. ; Zhou (2006), XL study on the expression of myeloid cell leukemia proteins and survivin and their relation with cell apoptosis in non - lymphoma, null, 1. ; Soleimanpour (null), as a Potential Target for Cancer Therapy Asian, Cancer, 16, 2015. ; Martinez (2004), Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival, Am J Pathol, 164. ; Phillips (2000), proliferation indexes in canine lymphoma, J Vet Diagn Invest, 12, 111. ; Banks (2000), does not inhibit caspase activity, Blood, 4002.